Applicability Of Lung Immune Prognostic Index (Lipi) To Predict Efficacy Of First-Line Pembrolizumab In Advanced Non-Small Cell Lung Cancer (Nsclc)
X. Mielgo Rubio,A. Gomez Rueda, M. Antonanzas, S. Falagan,J. A. Nunez,A. M. Sanchez Pena, I. Gomez-Barreda,E. Martinez Moreno,S. Cerezo Gonzalez, L. Cabezon Gutierrez,J. M. Sanchez Torres,B. E. Jimenez Munarriz, R. Cervera, C. Pangua Mendez,A. Calles Blanco,A. Lopez Martin,R. Lopez Castro,M. J. Sotelo Lezama, E. Perez Fernandez,P. Cruz ANNALS OF ONCOLOGY(2019)
AI 理解论文
溯源树
样例